Nrc Health (NRC) Price to Sales (2013 - 2026)

Nrc Health has disclosed Price to Sales across 14 years of filings, most recently posting 13.49 for Q2 2026.

• In Q2 2026, Price to Sales rose 18.3% year-over-year to 13.49; the TTM figure through Jun 2026 stood at 3.41 (up 23.35% YoY), while the FY2025 annual figure was 3.09, up 8.66% from the prior year.
• Price to Sales came in at 13.49 for Q2 2026 at Nrc Health, up from 11.0 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 51.92 in Q1 2022 to a low of 8.37 in Q3 2025.
• Average Price to Sales over 5 years is 22.22, with a median of 19.86 recorded in 2022.
• Year-over-year, Price to Sales slumped 67.59% in 2025 and advanced 26.67% in 2026.
• Over 5 years, Price to Sales stood at 24.08 in 2022, then advanced by 4.69% to 25.21 in 2023, then sank by 56.24% to 11.03 in 2024, then climbed by 9.43% to 12.07 in 2025, then rose by 11.74% to 13.49 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 13.49 in Q2 2026, 11.0 in Q1 2026, and 12.07 in Q4 2025.